Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Global Proteomic Market Size to reach 58.5 Billion US Dollar by 2027

Global Proteomic Market analysis, segmented by Product and services Type (Instrumentation Technology, Software Services and Reagents). By Application Type (Clinical diagnosis, Drug Discovery, Other Application). By region Regional Forecasting 2020-2027

Product Code: HALB_95016293
Publish Date: 15-11-2020
Page: 200

Global Proteomic Market was valued at 19.5 Billion US Dollar in 2020 and expected to grow with a CAGR 14.7%. Proteomic refers to the set of proteins which produced in an organism system. Proteomic relies on the basic technological fundaments such as Peptide Mixtures, Fractionate Complex Protein and Mass Spectrometry (MS) to identify individual protein. Most Proteomic Discoveries has been directed towards the cancer research, Drug Research and Biomarker research. Additionally, increasing demand for Medicine is expected to grow the proteomic market in forecasting years. Technological Advancement and increasing demand for Personalized medicine are key driven factors of the global Proteomic Market. For Instances, as per Personalized Medicine Coalition, the report shows that the number of personalized medicines on the market in the United States has grown from 132 in 2016 to 286 in 2020. Despite that high cost of instrument is the restraint in Proteomic Market during forecasting years
The regional analysis of the Proteomic Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World.In which North America is dominating the market and expected to do the same in forecasting years in view of its innovative next generation therapeutics and extensive research .However, Asia Pacific Market is Expected to grow during Forecasting years primarily due to the Rising awareness of personalized therapeutics and increasing investment by government and private sectors. .

Key Players in Global Proteomic Market
Thermo Fisher Scientific, Inc. (US)
Agilent Technologies, Inc. (US)
GE Healthcare (US)
Bio-Rad Laboratories, Inc. (US)
Danaher Corporation (US)
Luminex Corporation (US)
Bruker Corporation (US)
Merck KGaA (Germany)
Water Corporation (US)
PerkinElmer, Inc. (US)
Creative Proteomics (US)
Promega Corporation (US)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product and service Type:
Instrumentation Technology
Software Services

By Application Type:
Clinical Diagnosis
Drug Discovery
Other Application

By Region:
North America


Asia Pacific

Latin America
Rest of LA

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of Global Proteomic Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Proteomic Market, by Product and Service Type, 2018-2027 (USD Billion)
1.2.2. Proteomic Market, by Application Type, 2018-2027 (USD Billion)
1.2.3. Proteomic Market, By Region, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Proteomic Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Proteomic Market Dynamics
3.1. Proteomic Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Proteomic Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Proteomic Market, by Product and Service Type
5.1. Market Snapshot
5.2. Global Proteomic Market by Source, Performance – Potential Analysis
5.3. Global Proteomic Market Estimates & Forecasts by Product and Service Type 2018-2027 (USD Billion)
5.4. Proteomic Market, Sub Segment Analysis
5.4.1 Instrumentation Technology
5.4.2 Software and Services
5.4.3 Reagents
Chapter 6. Global Proteomic Market, by Application Type
6.1. Market Snapshot
6.2. Global Proteomic Market by Source, Performance – Potential Analysis
6.3. Global Proteomic Market Estimates & Forecasts by Application Type 2018-2027 (USD Billion)
6.4. Proteomic Market, Sub Segment Analysis
6.4.1. Clinical Diagnosis
6.4.2. Drug Discovery
6.4.3. Other Application
Chapter 7. Global Proteomic Market, Regional Analysis
7.1. Proteomic Market, Regional Market Snapshot
7.2. North America Proteomic Market
7.2.1. U.S. Proteomic Market Product and Service Type breakdown estimates & forecasts, 2018-2027 Application Type breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Proteomic Market
7.3. Europe Proteomic Market Snapshot
7.3.1. U.K. Proteomic Market
7.3.2. Germany Proteomic Market
7.3.3. France Proteomic Market
7.3.4. Spain Proteomic Market
7.3.5. Italy Proteomic Market
7.3.6. Rest of Europe Proteomic Market
7.4. Asia-Pacific Proteomic Market Snapshot
7.4.1. China Proteomic Market
7.4.2. India Proteomic Market
7.4.3. Japan Proteomic Market
7.4.4. Australia Proteomic Market
7.5. Latin America Proteomic Market Snapshot
7.6. Rest of The World Proteomic Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profile
8.2.1. Thermo Fisher Scientific, Inc. (US) Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
8.2.2. Agilent Technologies, Inc. (US)
8.2.3. GE Healthcare (US)
8.2.4. Bio-Rad Laboratories, Inc. (US)
8.2.5. Danaher Corporation (US)
8.2.6. Luminex Corporation (US)
8.2.7. Bruker Corporation (US)
8.2.8. Merck KGaA (Germany)
8.2.9. Water Corporation (US)
8.2.10. PerkinElmer, Inc. (US)

Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Primary Research Sources:

  • Interview conducted with raw material suppliers & manufacturers.
  • Interview conducted with manufacturers, suppliers & distributors, researchers, & representatives of regulatory bodies.
  • Interview conducted with market players, industry experts, & independent consultants.
  • Secondary Research Sources:
  • Purchased Database: D&B Hoovers, Bloomberg, Inc., Business Information Industry Association, NAICS Association.
  • Internal Database: White papers, Certified Publications, Articles by Recognized Authors and Regulatory Bodies.
  • Government Databases: Food and Agriculture Organization (FAO), European Industrial Hemp Association (EIHA), World Health Organization (WHO), Food and Drug Administration (FDA), International Telecommunication Union (ITU), United States Department of Agriculture (USDA), International organization of Motor Vehicle Manufacturers (OICA).

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now